Dandelion Science is developing a Generative Neuromodulation™ platform that utilizes Programmable Therapeutics to precisely modulate neural activity and program network dynamics in the brain. This technology aims to create targeted treatments for neurological disorders, overcoming the limitations of traditional neurochemical therapies that often have broad and harmful effects.
Funding
$75K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
COIAFounders
Product
Problem
Current treatments for brain disorders that target neurochemistry often have broad and harmful effects on neurofunction. This lack of precision can lead to suboptimal outcomes and unwanted side effects for patients.
Solution
Dandelion Science is developing a Generative Neuromodulation™ platform that uses Programmable Therapeutics™ to precisely modulate neural activity and program network dynamics in the brain. This platform leverages generative artificial intelligence (AI) to synthesize precision sensory stimulation therapies on demand. By targeting the brain's data pathways, Dandelion aims to create targeted treatments for neurological disorders, offering a more precise and effective approach compared to traditional neurochemical therapies. The platform emulates the way in which the brain itself processes information, holding promise for developing therapies that precisely match the complex dysfunctions they are intended to treat.
Target Audience
The primary target audience includes individuals and organizations involved in treating brain disorders, such as pharmaceutical companies, neurologists, psychiatrists, and clinical researchers.
Features
- Generative AI-driven platform for synthesizing precision sensory stimulation therapies
- Programmable Therapeutics™ to modulate neural activity and program network dynamics
- Technology platform designed to support drug development within neurology and psychiatry at the data-processing level
- Collaboration with neuroimaging systems to advance the technology platform